Annals of General Psychiatry

Annals of General Psychiatry is an open-access psychiatry journal published by BioMed Central, launched in 2002 and covering clinical psychiatry, psychopharmacology and translational neuroscience, with a 2025 Journal Impact Factor of 5.8.《普通精神病学年鉴》（Annals of General Psychiatry）由（BioMed Central）出版，2002 年创刊，为开放获取期刊，覆盖临床精神病学、精神药理学与转化神经科学，2025 年期刊影响因子为 5.8。

Scope

• The journal addresses general and adult psychiatry as a whole rather than a single subspecialty, and works within an evidence-based biopsychosocial framework.本刊面向普通精神病学与成人精神病学的整体而非单一亚专科，并在循证的生物心理社会框架内展开。
• Clinical psychiatry is the core, covering mood disorders, anxiety, psychotic disorders, personality disorders and their assessment and treatment.临床精神病学是核心，涵盖心境障碍、焦虑障碍、精神病性障碍、人格障碍及其评估与治疗。
• Psychopharmacology receives sustained attention, including trials of antipsychotics, antidepressants and mood stabilisers and the management of their adverse effects.精神药理学受到持续关注，包括抗精神病药、抗抑郁药与心境稳定剂的临床试验及其不良反应管理。
• Psychotherapies and psychosocial interventions are weighed alongside drug treatment, and meta-analytic syntheses of the trial literature are explicitly welcomed.心理治疗与社会心理干预同药物治疗并列考察，对试验文献的荟萃分析亦明确欢迎。
• Suicide, self-harm and crisis research forms a distinct strand, spanning risk assessment, prevention and support for the bereaved.自杀、自伤与危机研究构成独立主线，涉及风险评估、预防以及对丧亲者的支持。
• Digital and precision psychiatry, global mental health, and policy and services research complete the current scope.数字精神病学与精准精神病学、全球精神卫生，以及政策与服务研究，构成本刊当前的完整收稿范围。

History

• The journal was launched in September 2002 by BioMed Central as Annals of General Hospital Psychiatry, an online-only open-access title.本刊于 2002 年 9 月由（BioMed Central）以《综合医院精神病学年鉴》（Annals of General Hospital Psychiatry）之名创办，为纯在线开放获取期刊。
• It took its present name on 1 January 2005, because the original title led authors to assume that only consultation-liaison and psychosomatic medicine fell within scope.2005 年 1 月 1 日改用现名，原因是原刊名使作者误以为本刊只收会诊联络精神病学与心身医学稿件。^[1]
• BioMed Central, based in London, was later absorbed into Springer Nature, and the journal is now hosted on the Springer Nature Link platform.总部位于伦敦的（BioMed Central）其后并入（Springer Nature），本刊现于（Springer Nature Link）平台发布。
• It has never carried a print edition, so it holds only an electronic ISSN and publishes continuously rather than in numbered issues.本刊从未出纸本，仅有电子（ISSN），论文连续出版而不编入编号期次。
• It appears in Science Citation Index Expanded and the Social Science Citation Index, and also in PubMed, PubMed Central, PsycINFO, Scopus and DOAJ.本刊被（Science Citation Index Expanded）与（Social Science Citation Index）收录，同时进入（PubMed）、（PubMed Central）、（PsycINFO）、（Scopus）与（DOAJ）。
• The 2025 Journal Impact Factor is 5.8, against 3.1 in 2024 and 3.301 in 2022, ranking the journal 31st among 293 psychiatry titles, with a median of 32 days to first decision.2025 年期刊影响因子为 5.8，2024 年为 3.1，2022 年为 3.301，在 293 种精神病学期刊中列第 31 位，初审中位时间为 32 天。

Editors

• Maurizio Pompili, professor of psychiatry at Sapienza University of Rome, is editor-in-chief, and his own research centres on suicide risk and prevention.罗马大学的 Maurizio Pompili 任主编，其本人的研究集中于自杀风险与预防。
• Twelve section editors divide the field, among them bipolar disorder, child and youth psychiatry, forensic psychiatry and ethics, meta-analyses, mood disorders, neurobiology, obsessive-compulsive disorder and psychopharmacology.十二位分栏编辑划分领域，包括双相障碍、儿童与青少年精神病学、司法精神病学与伦理、荟萃分析、心境障碍、神经生物学、强迫症与精神药理学。
• Heinz Grunze of Klinikum am Weissenhof leads the bipolar section, while Siegfried Kasper of the Medical University of Vienna and Michael Thase of the University of Pennsylvania share psychopharmacology.（Klinikum am Weissenhof）的 Heinz Grunze 负责双相障碍，维也纳医科大学的 Siegfried Kasper 与宾夕法尼亚大学的 Michael Thase 共同负责精神药理学。
• Igor Galynker of the Icahn School of Medicine at Mount Sinai leads mood disorders, and Xenia Gonda of Semmelweis University leads suicidality and self-destructive behaviour.西奈山伊坎医学院的 Igor Galynker 负责心境障碍，塞梅尔维斯大学的 Xenia Gonda 负责自杀与自伤行为。
• Peijun Ju of the Shanghai Mental Health Center covers translational neuroscience, and the wider board of roughly thirty-five members is drawn from Europe, North America and Asia.上海市精神卫生中心的 Peijun Ju 负责转化神经科学，约三十五人的编委会成员来自欧洲、北美与亚洲。
• Manuscripts are handled by the editor-in-chief or the relevant section editor and sent to external referees, and the journal follows the guidance of COPE and the ICMJE.稿件由主编或相关分栏编辑处理并送外部评审，本刊遵循出版伦理委员会（COPE）与国际医学期刊编辑委员会（ICMJE）的规范。